Blog

Understanding the Updated EU CLP Classes: Enhancing Chemical Safety in Europe

The European Chemicals Agency (ECHA) has introduced significant updates to the European Union (EU) CLP (Classification, Labelling, and Packaging) regulation, strengthening its framework for classifying and managing chemical hazards. These updates reflect scientific advancements and aim to protect human health and the environment from potential chemical risks. 

An Introduction to Safety Pharmacology: Assessing Drug Risks and Protecting Patient Safety

Before a drug can enter clinical trials in humans, it must undergo rigorous safety evaluations to assess its potential risks. This includes identifying not only mild adverse effects, such as headaches or dizziness, but also identifying or predicting life threatening toxicities that may arise.

Endocrine Disruptors: A Hidden Threat

In today’s world, invisible yet potent chemicals known as endocrine disruptors (EDCs) are everywhere—from cosmetics to food packaging. These chemicals mimic hormones and interfere with the endocrine system, leading to serious health issues like reproductive disorders, diabetes, cancer, and developmental delays.

Understanding OECD and ICH Guidelines: Harmonizing Safety Standards and Reducing Animal Testing

The Organization for Economic Co-operation and Development (OECD) and the International Council for Harmonization of Technical Requirements for Pharmaceuticals for Human Use (ICH) both play crucial roles in harmonizing global regulations on chemicals and drugs to ensure their safe use in humans and the environment.

The Best Pre-Clinical Development Services

The Best Pre-Clinical Development Services

Pre-clinical studies in the Drug Discovery and Development process serve as the critical bridge between in vitro and in silico models and the introduction of new treatments to human clinical trials. This phase comprehends any research activity with a drug or treatment before testing in human volunteers.

Pages